HB 713 2025
CODING: Words stricken are deletions; words underlined are additions.
hb713-00
Page 1 of 4
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
A bill to be entitled 1
An act relating to obesity treatment and diabetes 2
prevention; creating s. 381.73531, F.S.; providing 3
definitions; requiring the Agency for Health Care 4
Administration to provide certain treatments for the 5
chronic disease of obesity; providing for coverage of 6
and access to such treatments; authoriz ing rulemaking; 7
providing construction; requiring the agency to 8
provide coverage through Medicaid reimbursement for 9
the diabetes prevention program under certain 10
circumstances; authorizing the Department of Health to 11
apply for a state plan amendment under certain 12
circumstances; providing an effective date. 13
14
Be It Enacted by the Legislature of the State of Florida: 15
16
Section 1. Section 381.73531, Florida Statutes, is created 17
to read: 18
381.73531 Obesity treatment and d iabetes prevention.— 19
(1) DEFINITIONS.—For purposes of this section, the term: 20
(a) "Agency" means the Agency for Health Care 21
Administration. 22
(b) "Diabetes prevention program" means structured 23
behavioral health changes provided to an eligible individual by 24
a diabetes prevention progra m supplier for the purpose of 25
HB 713 2025
CODING: Words stricken are deletions; words underlined are additions.
hb713-00
Page 2 of 4
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
preventing or delaying the onset of Type 2 diabetes which 26
follows a curriculum approved by the Centers for Disease Control 27
and Prevention. 28
(c) "Diabetes prevention program supplier" means an entity 29
that is recognized under t he Diabetes Prevention Recognition 30
Program of the Centers for Disease Control and Prevention and 31
offers a program through an allowable Diabetes Prevention 32
Recognition Program delivery mode including in -person or through 33
telehealth as defined in s. 456.47(1 ). 34
(d) "FDA-approved obesity medication" means any medication 35
approved by the federal Food and Drug Administration (FDA) with 36
an indication for chronic weight management in patients with an 37
obesity diagnosis. 38
(e) "Intensive health behavior and lifestyl e treatment" 39
means an evidence-based, intensive, multi -component behavioral 40
or lifestyle modification intervention that supports healthy 41
weight management and is delivered in -person or through 42
telehealth as defined in s. 456.47(1). 43
(f) "Metabolic and bar iatric surgery" means any surgical 44
intervention included in the most current American Society for 45
Metabolic and Bariatric Surgery and International Federation for 46
the Surgery of Obesity and Metabolic Disorders (ASMBS-IFSO) 47
guidelines on indications for met abolic and bariatric surgery. 48
(2)(a) The agency shall provide treatments for the chronic 49
disease of obesity, which shall include, but not be limited to, 50
HB 713 2025
CODING: Words stricken are deletions; words underlined are additions.
hb713-00
Page 3 of 4
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
all of the following: 51
1. Intensive health behavior and lifestyle treatment. 52
2. Metabolic and bari atric surgery. 53
3. FDA-approved obesity medications. 54
(b) Coverage criteria for FDA -approved obesity medications 55
may not be more restrictive than the FDA -approved indications 56
for those treatments. 57
(c) Intensive health behavior and lifestyle treatment may 58
include interventions certified by or recognized by the Centers 59
for Disease Control and Prevention or recommended by current 60
clinical standards of care. The services may be provided in -61
person or through telehealth as defined in s. 456.47(1). 62
(d) The agency shall adopt rules to implement this 63
subsection and notify health care providers in writing about the 64
coverage of treatment for the chronic disease of obesity 65
provided pursuant to this subsection. 66
(e) This subsection does not prohibit the Departmen t of 67
Health from applying utilization management review procedures to 68
determine the medical necessity for treatment of the chronic 69
disease of obesity under this section if appropriateness and 70
medical necessity determinations are made in the same manner as 71
those determinations are made for the treatment of any other 72
illness, condition, or disorder covered by a contract. 73
(3)(a) The agency shall provide coverage for the diabetes 74
prevention program. 75
HB 713 2025
CODING: Words stricken are deletions; words underlined are additions.
hb713-00
Page 4 of 4
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
(b) Beginning July 1, 2025, Medicaid shall reimburse a 76
provider for an enrollee's participation in the diabetes 77
prevention program if the enrollee: 78
1. Meets the program eligibility requirements. 79
2. Has not previously participated in the program while 80
enrolled in Medicaid. 81
(c) The department may apply for a state plan amendment if 82
necessary to implement this section. 83
Section 2. This act shall take effect July 1, 2025. 84